Phase I/II Gene Transfer Clinical Trial of scAAV9.U1a.hSGSH
Phase of Trial: Phase I/II
Latest Information Update: 04 Aug 2017
At a glance
- Drugs ABO 102 (Primary)
- Indications Mucopolysaccharidosis III
- Focus Adverse reactions; First in man
- Sponsors Abeona therapeutics
- 19 May 2017 Results from this trial published in an Abeona Therapeutics Media Release.
- 19 May 2017 According to an Abeona Therapeutics media release, top-line data from this trial will be presented at upcoming conference of American Society Gene and Cell Therapy (ASGCT).
- 12 May 2017 Updated data (n=3 Cohort 1, n=2 Cohort 2) from this trial published in an Abeona Therapeutics Media Release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History